Angiotensin Converting Enzyme Inhibition in Children With Mitral Regurgitation
Status:
Terminated
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy and safety of angiotensin converting enzyme inhibition
(ACE-I) therapy for the treatment of mitral regurgitation (MR).
Phase:
Phase 3
Details
Lead Sponsor:
University of Utah
Collaborators:
National Heart, Lung, and Blood Institute (NHLBI) Pediatric Heart Network